Form Bio

Form Bio is a biotechnology company based in Austin, Texas, founded in 2022. The company focuses on developing cell and gene therapies through the use of computational biology and artificial intelligence. Its mission is to empower scientists by accelerating discoveries and reducing the time and cost associated with therapeutic development. The company offers a comprehensive computational platform that enhances the development process of cell and gene therapies. This platform includes tools for data management, workflows, visualization, and AI integration, which are essential for biotech companies in discovering and validating new therapies. Form Bio's platform is particularly effective in managing complex bioinformatics data, enabling faster analysis and facilitating breakthroughs in drug discovery. Form Bio has established key partnerships with industry leaders like NVIDIA and PacBio, enhancing its influence in the biotechnology sector. The company is currently in the Series B funding stage, having raised a total of $180 million, indicating strong growth potential and a commitment to advancing technology in life sciences.